Skip to main content
Log in

Generic and therapeutic substitution: ethics meets health economics

  • Letter to the Editor
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. AlAmeri M, Epstein M, Johnston A. Generic and therapeutic substitutions: are they always ethical in their own terms? Pharm World Sci. 2010;32(6):691–5.

    Article  PubMed  Google Scholar 

  2. Plans-Rubio P. The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices. Am J Cardiovasc Drugs. 2010;10(6):369–82.

    Article  PubMed  Google Scholar 

  3. Kohl H, Shrank WH. Increasing generic drug use in Medicare Part D: the role of government. J Am Geriatr Soc. 2007;55(7):1106–9.

    Article  PubMed  Google Scholar 

  4. Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Ann Pharmacother. 2009;43(10):1583–97.

    Article  PubMed  CAS  Google Scholar 

  5. Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, et al. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs. 2010;70(5):605–21.

    Article  PubMed  CAS  Google Scholar 

  6. Gagne JJ, Avorn J, Shrank WH, Schneeweiss S. Refilling and switching of antiepileptic drugs and seizure-related events. Clin Pharmacol Ther. 2010;88(3):347–53.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Simoens.

Additional information

The author holds the EGA chair ‘European policy towards generic medicines’.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simoens, S. Generic and therapeutic substitution: ethics meets health economics. Int J Clin Pharm 33, 469–470 (2011). https://doi.org/10.1007/s11096-011-9500-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-011-9500-7

Keywords

Navigation